Top Ranked Value Stocks to Buy for May 28th

CMI PERI NOA XELB

Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 28th:

North American Construction Group Ltd. (NOA - Free Report) : This heavy construction and mining services provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.9% over the last 60 days.

North American Construction has a price-to-earnings ratio (P/E) of 8.32, compared with 10.60 for the industry. The company possesses a Value Score of A.

Xcel Brands, Inc. (XELB - Free Report) : This consumer products company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 26.9% over the last 60 days.

Xcel has a price-to-earnings ratio (P/E) of 3.25, compared with 13.30 for the industry. The company possesses a Value Score of A.

Cummins Inc. (CMI - Free Report) : This diesel and natural gas engines manufacturer has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 4.7% over the last 60 days.

Cummins has a price-to-earnings ratio (P/E) of 9.88, compared with 10.00 for the industry. The company possesses a Value Score of B.

Perion Network Ltd. (PERI - Free Report) : This technology company that delivers advertising solutions to brands, agencies and publishers has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 18.8% over the last 60 days.

Perion Network has a price-to-earnings ratio (P/E) of 8.37 compared with 17.80 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>